APP13002
Bacterial conjunctivitis, keratitis, blepharitis, Meibomian Gland Dysfunction
Preclinical/ClinicalActive
Key Facts
Indication
Bacterial conjunctivitis, keratitis, blepharitis, Meibomian Gland Dysfunction
Phase
Preclinical/Clinical
Status
Active
Company
About Formosa Pharmaceuticals
A clinical-stage biotech company developing ophthalmology and oncology therapies using its proprietary APNT® nanoparticle platform and ADC technology.
View full company profile